Medtronic PLC Form 4 insider transactions

Medtronic announces a share exchange offer allowing shareholders to swap Medtronic shares for MiniMed shares at a discount as part of MiniMed's separation into an independent company.

Medtronic plc announced an exchange offer to divest its MiniMed division, aiming to create a more focused Medtronic and an independent leader in diabetes therapies.

Medtronic plc is offering its shareholders an exchange of Medtronic ordinary shares for newly issued shares of MiniMed Common Stock to complete the divestment of its Diabetes Operating Unit.

Medtronic plc announced an exchange offer allowing shareholders to swap Medtronic shares for MiniMed Group, Inc. stock, aiming for a tax-free separation.

MiniMed has filed a Form S-4 Registration Statement for Medtronic's offer to exchange up to 225,361,295 MiniMed shares for outstanding Medtronic ordinary shares, marking a key step towards MiniMed's full separation.

Michael Marinaro, EVP, Pres MedSurg and Americas of Medtronic plc, reported a transaction in 1,084 shares of common stock on August 20, 2026.

Denise L. Blomquist, Chief Accounting Officer of Medtronic plc, reported multiple transactions in common stock on July 31, 2026.

Matthew R. Walter, SVP, Chief HR Officer of Medtronic plc, reported multiple transactions in common stock on July 31, 2026.

Kweli Thompson, EVP & President, Neuroscience of Medtronic plc, reported multiple transactions in common stock on July 31, 2026.

Michelle Quinn, EVP, GC and Secretary of Medtronic plc, reported multiple transactions in common stock on August 3, 2026.

Thierry Pieton, EVP & Chief Financial Officer of Medtronic plc, reported multiple transactions in common stock on August 3, 2026.

Michael Marinaro, EVP, Pres MedSurg and Americas of Medtronic plc, reported multiple transactions in common stock on July 31, 2026.

Harry Skip Kiil, EVP & President Cardiovascular of Medtronic plc, reported multiple transactions in common stock on July 31, 2026.

Geoffrey Martha, Chairman and CEO and a Director of Medtronic plc, reported multiple transactions in common stock on July 31, 2026.

Michelle Quinn, EVP, GC and Secretary of Medtronic plc, reported a transaction in 2,069 shares of common stock on July 28, 2026.

Medtronic plc reports a transaction where SVP, Chief HR Officer Walter Matthew R. sold 3,102 ordinary shares.

Medtronic plc executive Harry Skip Kiil reported the sale of company shares on June 8, 2026, totaling 4,189 ordinary shares.

EVP & President of Cardiovascular Harry Skip Kiil disposed of 6,817 Medtronic shares to cover tax obligations.

Medtronic Chairman and CEO Martha Geoffrey reported the withholding of 41,936 shares to cover tax obligations related to vested restricted stock units.

Medtronic EVP Michael Marinaro disposed of 7,471 shares to satisfy tax obligations related to vested restricted stock units.

SVP and Chief HR Officer Matthew R. Walter disposed of 2,840 shares of Medtronic plc to satisfy tax withholding obligations.

Medtronic Chief Accounting Officer Denise L. Blomquist reported the withholding of 237 ordinary shares to cover tax obligations related to vested restricted stock units.

Medtronic SVP and Chief HR Officer Matthew R. Walter acquired 9,149 ordinary shares following the settlement of performance-vesting units.

Medtronic EVP Brett A. Wall acquired 26,907 ordinary shares following the settlement of performance-vesting share units.

Medtronic Chairman and CEO Martha Geoffrey acquired 94,963 ordinary shares following the settlement of performance-vesting share units.

Medtronic EVP Michael Marinaro acquired 18,994 ordinary shares following the settlement of performance-vesting units.

Medtronic EVP Harry Skip Kiil acquired 15,195 ordinary shares following the settlement of performance-vesting share units.

Medtronic Chief Accounting Officer Denise Blomquist acquired 1,712 ordinary shares following the settlement of performance-vesting share units.

Medtronic plc reports a Form 4 filing detailing changes in beneficial ownership for SVP, Chief HR Officer Walter Matthew R.

Denise L. Blomquist, Chief Accounting Officer at Medtronic plc, reported transactions involving ordinary shares and restricted stock units.